iMOST (Instant Mobile Self-Test), Transforming Digital Health and Beyond
Accurate Instant Mobile Health Self-Test at Your Finger Tips, Anywhere, Anytime, Available and Affordable To Everyone
Press Release: Nov 16, 2021 - Essenlix, Partnering with Roche Norway, Won Norway Østfold Hospital System's "Patient At-Home Test" Innovation Partnership That Will Use Essenlix's iMOST™ as Test Platform
iMOST Video - The World's Smallest, Simplest, and Lowest-Cost Blood Count Device
Press Release: Nov 16, 2021 - Essenlix, Partnering with Roche Norway, Won Norway Østfold Hospital System's "Patient At-Home Test" Innovation Partnership That Will Use Essenlix's iMOST™ as Test Platform
iMOST Video - The World's Smallest, Simplest, and Lowest-Cost Blood Count Device
Essenlix, a digital health and wellness company, provides a game-changing instant mobile health self-test platform, iMOST, that allows any person to accurately perform a diagnostic/health test her/himself, anywhere, anytime, using a single drop of body fluid and a smartphone, all within 60 seconds, at a low cost, with the result sent immediately to professionals.
iMOST™ (Instant Mobile Self-Test), first of the type, is based on outside-the-box thinking and a fundamentally different paradigm. The new paradigm is realized through uniquely implementing nanotechnology, advance imaging, artificial intelligence/machine learning and new bio/chemical processes into diagnostic testing. iMOST delivers clinical lab-quality test results using a simple device, even when a sample, device, process, and operation are imperfect.
Diagnostic lab-testing is a vital and necessary procedure for diagnosing diseases and monitoring health conditions. The iMOST platform is removing one of the largest barriers in digital health by replacing a conventional inconvenient, time consuming, and expensive lab-test with an instant mobile self-test platform. Essenlix aims to make iMOST available to most of the world’s 7 billion population.
iMOST™ (Instant Mobile Self-Test), first of the type, is based on outside-the-box thinking and a fundamentally different paradigm. The new paradigm is realized through uniquely implementing nanotechnology, advance imaging, artificial intelligence/machine learning and new bio/chemical processes into diagnostic testing. iMOST delivers clinical lab-quality test results using a simple device, even when a sample, device, process, and operation are imperfect.
Diagnostic lab-testing is a vital and necessary procedure for diagnosing diseases and monitoring health conditions. The iMOST platform is removing one of the largest barriers in digital health by replacing a conventional inconvenient, time consuming, and expensive lab-test with an instant mobile self-test platform. Essenlix aims to make iMOST available to most of the world’s 7 billion population.